The global intraocular lens market size is expected to reach USD 6.17 billion by 2030, registering a CAGR of 4.63% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rise in the geriatric and diabetic population, which is prone to develop cataracts and other visual disorders, is expected to foster market growth. In addition, rising awareness regarding visual disorders, increase in healthcare spending, and government support to improve the healthcare infrastructure are some of the significant factors boosting the growth of the market.
Although the market has witnessed a bit of a downfall in overall sales during the first half of the pandemic, it is expected to recover and flourish during the forecast period. The restrictions and lockdowns imposed by the government affected the market negatively in terms of demand as well supply. While the volume of procedures drastically dropped down due to the change in healthcare priorities, the shutdown of manufacturing units led to the shortage in the supply of intraocular lenses. However, with the opening up of the economies and the introduction of vaccines, the market is expected to witness steady growth and earn significant profits during the forecast period.
The market for intraocular lenses was negatively affected during the pandemic due to the postponement and delaying of elective procedures. Cataract surgery is an elective procedure and therefore it was postponed to prevent the patients from contracting the virus. However, the market has begun to recover and the market players and ophthalmologists are focusing on recovering the losses and making the optimum use of technology to overcome the losses incurred during the pandemic. This will help the market to grow despite the challenges possessed by the pandemic.
Request a free sample copy or view report summary: Intraocular Lens Market Report
By product, the multifocal intraocular lens segment dominated the market in 2023 owing to the higher adoption due to its benefits such as high precision and improved visualization
Based on end use, the hospitals segment held the largest revenue share in 2023 owing to the majority of cataract surgeries being performed in the hospitals and increasing cases of cataract
North America held the largest revenue share in 2023 owing to the rising incidence of cataracts and other ophthalmic disorders, well-defined regulatory guidelines, and favorable reimbursement scenarios in the region
Grand View Research has segmented the global intraocular lens market based on product, end-use, and region:
Intraocular Lens Product Outlook (Revenue, USD Million, 2018 - 2030)
Monofocal Intraocular Lens
Multifocal Intraocular Lens
Toric Intraocular Lens
Accommodative Intraocular Lens
Intraocular Lens End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ophthalmic Clinics
Ambulatory Surgery Centers
Eye Research Institutes
Intraocular Lens Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Intraocular Lens Market
Alcon, Inc.
Johnson and Johnson Vision Care, Inc.
Bausch & Lomb Incorporated
Carl Zeiss Meditec AG (ZEISS International)
Rayner
EyeKon Medical, Inc.
Lenstec, Inc.
HumanOptics AG
STAAR Surgical Company
HOYA CORPORATION
"The quality of research they have done for us has been excellent..."